رجوع
21
38
48
35
35
نطاق اليوم
KWD 41.50
KWD 42.70
نطاق 52 أسبوعًا
KWD 32.38
KWD 49.62
حجم التداول
1,722,718
متوسط 50 يوم / 200 يوم
KWD 43.04
/
KWD 41.57
الإغلاق السابق
KWD 42.36
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (633 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 14.2 | 0.2 |
| P/B | 5.2 | 2.8 |
| ROE % | 35.5 | 3.7 |
| Net Margin % | 33.7 | 3.9 |
| Rev Growth 5Y % | 12.8 | 9.7 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 44.11
+6.2%
Low: KWD 30.00
High: KWD 54.00
مكرر الربحية المستقبلي
14.51
ربحية السهم المستقبلية
KWD 2.95
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.32B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2031 |
KWD 5.48
KWD 4.92 – KWD 5.98
|
3.19B | 6 |
| FY2030 |
KWD 5.57
KWD 5.01 – KWD 6.09
|
3.42B | 5 |
| FY2029 |
KWD 4.77
KWD 2.26 – KWD 7.45
|
3.26B | 12 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | KWD 0.83 | KWD 0.94 | +13.3% |
| 2025-11-04 | KWD 0.69 | KWD 0.78 | +13.9% |
| 2025-07-28 | KWD 0.65 | KWD 0.75 | +15.4% |
| 2025-05-13 | KWD 0.36 | KWD 0.62 | +73.1% |
| 2025-02-11 | KWD 0.51 | KWD 0.55 | +7.8% |
| 2024-10-29 | KWD 0.35 | KWD 0.40 | +14.3% |
| 2024-08-06 | KWD 0.30 | KWD 0.77 | +156.7% |
| 2024-04-30 | KWD 0.28 | KWD 0.17 | -39.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 12.76% annually over 5 years — strong growth
Earnings grew 50.13% over the past year
ROE of 35.53% indicates high profitability
Net margin of 33.73% shows strong profitability
Debt/Equity of 0.08 — conservative balance sheet
Generating 844.34M in free cash flow
النمو
Revenue Growth (5Y)
12.76%
Revenue (1Y)6.98%
Earnings (1Y)50.13%
FCF Growth (3Y)122.63%
الجودة
Return on Equity
35.53%
ROIC28.02%
Net Margin33.73%
Op. Margin37.59%
الأمان
Debt / Equity
0.08
Current Ratio3.56
Interest Coverage0.00
التقييم
P/E Ratio
14.23
Forward P/E14.51
P/B Ratio5.15
EV/EBITDA12.41
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.98% | Revenue Growth (3Y) | 12.59% |
| Earnings Growth (1Y) | 50.13% | Earnings Growth (3Y) | 94.08% |
| Revenue Growth (5Y) | 12.76% | Earnings Growth (5Y) | 35.66% |
| Profitability | |||
| Revenue (TTM) | 2.32B | Net Income (TTM) | 782.57M |
| ROE | 35.53% | ROA | 27.51% |
| Gross Margin | 96.39% | Operating Margin | 37.59% |
| Net Margin | 33.73% | Free Cash Flow (TTM) | 844.34M |
| ROIC | 28.02% | FCF Growth (3Y) | 122.63% |
| Safety | |||
| Debt / Equity | 0.08 | Current Ratio | 3.56 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 14.23 | Forward P/E | 14.51 |
| P/B Ratio | 5.15 | P/S Ratio | 4.80 |
| PEG Ratio | 0.25 | Forward PEG | N/A |
| EV/EBITDA | 12.41 | Fwd EV/EBITDA | 7.83 |
| Forward P/S | 4.80 | Fwd Earnings Yield | 6.89% |
| FCF Yield | 7.58% | ||
| Market Cap | 11.13B | Enterprise Value | 10.83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.32B | 2.17B | 1.83B | 1.61B | 1.43B |
| Net Income | 782.57M | 521.27M | 207.77M | 182.28M | 231.06M |
| EPS (Diluted) | 2.78 | 1.76 | 0.65 | 0.56 | 0.72 |
| Gross Profit | 2.24B | 2.09B | 1.76B | 1.55B | 1.38B |
| Operating Income | 872.19M | 604.62M | 170.89M | 201.48M | 286.67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.84B | 2.95B | 2.94B | 3.07B | 2.62B |
| Total Liabilities | 683.10M | 703.49M | 678.45M | 583.06M | 405.62M |
| Shareholders' Equity | 2.16B | 2.24B | 2.26B | 2.49B | 2.21B |
| Total Debt | 173.04M | 190.82M | 189.94M | 190.17M | 51.27M |
| Cash & Equivalents | 482.49M | 217.37M | 262.99M | 501.20M | 647.17M |
| Current Assets | 1.44B | 1.47B | 1.32B | 1.62B | 1.83B |
| Current Liabilities | 405.64M | 403.77M | 394.28M | 324.36M | 337.59M |
درجات الاستراتيجيات
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#971 of 1058
Custom
Capital Light Compounder
#127 of 225
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#192 of 330
Custom
Balanced Risk
#121 of 151
Custom
Lower Risk
#114 of 139
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Capital Light Compounder
Mar 24, 2026
دخل
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
دخل
Balanced Risk
Mar 24, 2026
دخل
Lower Risk
Mar 24, 2026